share_log

Exas Science Shares Are Trading Higher After the Company Announced Data for Its Blood-based Colorectal Cancer Screening Test.

Exas Science Shares Are Trading Higher After the Company Announced Data for Its Blood-based Colorectal Cancer Screening Test.

Exas科学公司宣布其基于血液的结直肠癌筛查测试数据后,其股价上涨。
Benzinga ·  09/16 07:37

Exas Science Shares Are Trading Higher After the Company Announced Data for Its Blood-based Colorectal Cancer Screening Test.

Exas科学公司宣布其基于血液的结直肠癌筛查测试数据后,其股价上涨。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发